THE GASTRO EDITION:
UC RELIEF* STARTS HERE
Welcome to RINVOQ REELS —
a video library featuring your peers discussing clinical
data and sharing opinions about treating UC
Welcome to
RINVOQ REELS — a video
library featuring your
peers discussing clinical data and sharing opinions about treating UC
WELL-STUDIED SAFETY
Dr. Miguel Regueiro and Dr. Remo Panaccione present an overview of the RINVOQ clinical profile with a focus on the well‑studied safety results in UC.
Stringent Endpoints in UC
Stringent Endpoints
in UC
Dr. Miguel Regueiro and Dr. Remo Panaccione discuss evolving treatment guidelines and the stringent endpoints that RINVOQ achieved including endoscopic and histo-endoscopic outcomes.
*Clinical response per partial modified Mayo Score is a composite of Mayo stool frequency and rectal bleeding subscores and is defined as a decrease in total score ≥30% and ≥1 point from baseline and a decrease in rectal bleeding subscore ≥1 or rectal bleeding subscore of 0 or 1.
IR=intolerance or inadequate response; TNFi=tumor necrosis factor inhibitor; UC=ulcerative colitis
